ArticleJournal of nursing management2026
Self-Management Improves Long-Term CKD Prognosis: A 10-Year Retrospective Cohort Study From China.
Article in Journal of nursing management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Self-Management Improves Long-Term CKD Prognosis: A 10-Year Retrospective Cohort Study From China.Journal of nursing management · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Self-management (SMP) is a novel treatment comprised of multidimensional interventions. Researchers have reported its reliable effects on short-term improvements in surrogate indicators like 24-h urinary protein excretion and systolic blood pressure. However, whether it has any effect on long-term changes in other surrogate indicators and chronic kidney disease (CKD) endpoints remains unclear. Methods: Patients with CKD stages 3-4 were grouped into either a SMP group or a nonself-management (non-SMP) group whether they had complied any of five characterized elements: regular visits, medication adjustment, nutritional intervention, lifestyle modification, education, and behavior guide. We used 1:1 nearest-neighbor propensity score matching (PSM) to balance between-group differences. Cox regression was used to explore the long-term association between SMP and composite outcomes (all-cause mortality, end-stage kidney disease (ESKD), ≥ 50% decline in estimated glomerular filtration rate (eGFR), or doubling of serum creatinine (SCr) from baseline). Linear mixed-effects (LME) model and marginal means comparisons were used to surrogate indicators analysis. Results: The study included 1160 patients with a median follow-up of 27.20 months. Among them, 580 individuals were in the SMP group and 580 were in the non-SMP group. In the non-SMP group, the median follow-up was 24.48 (12.21, 43.39) months with 174 (30.00%) events, whereas the SMP group had a median follow-up of 29.34 (14.75, 42.00) months with 134 (23.10%) composite outcomes. Participation in a SMP program was associated with a 30.9% reduction in CKD progression risk (hazard ratio (HR) of composite outcome: 0.691, 95% CI: 0.549-0.869, and Conclusion: SMP programs are associated with a 30.9% reduction in CKD progression risk and improvements in kidney function and nutrition-related surrogate markers, benefiting CKD patients in stages 3-4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.